1. Home
  2. HUSA vs APRE Comparison

HUSA vs APRE Comparison

Compare HUSA & APRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUSA
  • APRE
  • Stock Information
  • Founded
  • HUSA N/A
  • APRE 2006
  • Country
  • HUSA United States
  • APRE United States
  • Employees
  • HUSA N/A
  • APRE N/A
  • Industry
  • HUSA Oil & Gas Production
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HUSA Energy
  • APRE Health Care
  • Exchange
  • HUSA Nasdaq
  • APRE Nasdaq
  • Market Cap
  • HUSA 16.9M
  • APRE 15.8M
  • IPO Year
  • HUSA N/A
  • APRE 2019
  • Fundamental
  • Price
  • HUSA $1.67
  • APRE $3.85
  • Analyst Decision
  • HUSA
  • APRE Strong Buy
  • Analyst Count
  • HUSA 0
  • APRE 2
  • Target Price
  • HUSA N/A
  • APRE $15.50
  • AVG Volume (30 Days)
  • HUSA 501.1K
  • APRE 33.0K
  • Earning Date
  • HUSA 11-14-2024
  • APRE 11-07-2024
  • Dividend Yield
  • HUSA N/A
  • APRE N/A
  • EPS Growth
  • HUSA N/A
  • APRE N/A
  • EPS
  • HUSA N/A
  • APRE N/A
  • Revenue
  • HUSA $640,348.00
  • APRE $1,310,839.00
  • Revenue This Year
  • HUSA N/A
  • APRE $134.21
  • Revenue Next Year
  • HUSA N/A
  • APRE N/A
  • P/E Ratio
  • HUSA N/A
  • APRE N/A
  • Revenue Growth
  • HUSA N/A
  • APRE 130.31
  • 52 Week Low
  • HUSA $0.96
  • APRE $2.15
  • 52 Week High
  • HUSA $2.57
  • APRE $8.85
  • Technical
  • Relative Strength Index (RSI)
  • HUSA 58.68
  • APRE 56.63
  • Support Level
  • HUSA $1.56
  • APRE $3.34
  • Resistance Level
  • HUSA $2.06
  • APRE $3.83
  • Average True Range (ATR)
  • HUSA 0.17
  • APRE 0.42
  • MACD
  • HUSA 0.04
  • APRE 0.01
  • Stochastic Oscillator
  • HUSA 51.25
  • APRE 36.04

About HUSA Houston American Energy Corporation

Houston American Energy Corp is an independent oil and gas company focused on the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties. Its properties, and operations, are in the U.S. Permian Basin, the U.S. Gulf Coast region, particularly Texas and Louisiana, and the South American country of Colombia. The company's exploration and development projects are focused on existing property interests, and future acquisition of additional property interests, in the Texas Permian Basin, the onshore Texas and Louisiana Gulf Coast region, and the South American country of Colombia. The Company majorly has operations in two geographical areas, the United States and Colombia.

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

Share on Social Networks: